|
Results
23-Jul-21
|
|
|
|
|
Analysis
|
|
Atul
|
PBT up 35%
|
|
|
Atul
consolidated net sales increased 63.53% to Rs 1080.2 crore in Q1FY22 compared
to Q1FY21. Sales of Life Science
Chemicals segment has gone up 30.14% to Rs 352.49 crore (accounting for 31.45%
of total sales). Sales of Performance
& Other Chemicals segment has gone up 79.20% to Rs 753.51 crore (accounting
for 67.24% of total sales). Sales of
Others segment rose 68.77% to Rs 14.70 crore (accounting for 1.31% of total
sales). Inter-segment sales rose Rs
39.50 crore to Rs 40.50 crore.
Operating
profit margin has slumped from 24.02% to 21.86%, leading to 48.82% rise in
operating profit to Rs 236.11 crore. Raw material cost as a % of total sales
(net of stock adjustments) increased from 38.15% to 47.19%. Purchase of
finished goods cost fell from 4.75% to 3.66%.
Employee cost decreased from 11.23% to 6.97%. Other expenses fell from
21.79% to 21.54%. Power and Oil fuel
cost rose from 8.10% to 8.68%.
Other
income fell 27.12% to Rs 29.62 crore. Profit before interest, tax and other
unallocable items (PBIT) has jumped 53.70% to Rs 209.14 crore. PBIT of Life Science Chemicals segment fell
3.43% to Rs 49.29 crore (accounting for 23.57% of total PBIT). PBIT of Performance & Other Chemicals
segment rose 82.74% to Rs 156.33 crore (accounting for 74.75% of total
PBIT). PBIT of Others reported profit of
Rs 3.52 crore compared to loss of Rs 0.52 crore.
PBIT
margin of Life Science Chemicals segment fell from 18.84% to 13.98%. PBIT margin of Performance & Other
Chemicals segment rose from 20.35% to 20.75%.
PBIT margin of Others segment rose from negative 5.97% to 23.95%. Overall PBIT margin fell from 19.44% to
18.66%.
Provision
for interest fell 22.85% to Rs 2.06 crore. Provision for depreciation rose
30.62% to Rs 43.26 crore. Profit before tax grew 34.80% to Rs 220.41
crore. Share of profit/loss was 592.86%
higher at Rs 1.94 crore. Provision for
tax was expense of Rs 57.2 crore, compared to Rs 45.85 crore. Effective tax rate was 25.73% compared to
27.99%.
Net
profit attributable to owners of the company increased 40.89% to Rs 165.94
crore.
Full year results
analysis
Net
sales (including other operating income) of Atul has declined 8.83% to Rs
3731.47 crore. Sales of Life Science
Chemicals segment has gone down 2.84% to Rs 1,216.37 crore (accounting for
31.30% of total sales). Sales of
Performance & Other Chemicals segment has gone down 12.15% to Rs 2,621.88
crore (accounting for 67.46% of total sales).
Sales of Others segment rose 31.63% to Rs 48.48 crore (accounting for 1.25%
of total sales). Inter-segment sales
came down from Rs 180.22 crore to Rs 155.26 crore.
Operating
profit margin has jumped from 22.04% to 24.58%, leading to 1.68% rise in
operating profit to Rs 917.12 crore. Raw
material cost as a % of total sales (net of stock adjustments) decreased from
44.39% to 42.25%. Purchase of finished
goods cost rose from 3.68% to 4.05%.
Employee cost increased from 7.36% to 8.18%. Other expenses fell from 22.51% to 21.33%.
Power and Oil fuel cost fell from 9.12% to 8.16%.
Other
income rose 31.96% to Rs 102.98 crore. Profit before interest, tax and other
unallocable items (PBIT) has slumped 1.58% to Rs 825.03 crore. PBIT of Life Science Chemicals segment fell
1.61% to Rs 219.57 crore (accounting for 26.61% of total PBIT). PBIT of Performance & Other Chemicals
segment fell 1.62% to Rs 594.16 crore (accounting for 72.02% of total
PBIT). PBIT of Others segment rose 1.53%
to Rs 11.30 crore (accounting for 1.37% of total PBIT).
PBIT
margin of Life Science Chemicals segment rose from 17.82% to 18.05%. PBIT margin of Performance & Other
Chemicals segment rose from 20.24% to 22.66%.
PBIT margin of Others segment fell from 30.22% to 23.31%. Overall PBIT margin rose from 19.62% to
21.23%.
Provision
for interest fell 0.53% to Rs 9.35 crore.
Loan funds rose to Rs 101.72 crore as of 31 March 2021 from Rs 96.97
crore as of 31 March 2020. Inventories
rose to Rs 594.14 crore as of 31 March 2021 from Rs 503.37 crore as of 31 March
2020. Sundry debtors were higher at Rs
733.23 crore as of 31 March 2021 compared to Rs 719.73 crore as of 31 March
2020. Cash and bank balance rose to Rs
348.18 crore as of 31 March 2021 from Rs 35.37 crore as of 31 March 2020. Investments rose to Rs 1,361.05 crore as of
31 March 2021 from Rs 1,137.31 crore as of 31 March 2020 .
Provision
for depreciation rose 4.69% to Rs 136.32 crore.
Fixed assets increased to Rs 1,626.10 crore as of 31 March 2021 from Rs
1,463.88 crore as of 31 March 2020.
Intangible assets increased from Rs 29.14 crore to Rs 41.98 crore.
Profit
before tax grew 4.04% to Rs 874.43 crore.
Share of profit/loss was 45.58% higher at Rs 7.25 crore. Provision for tax was expense of Rs 221.66
crore, compared to Rs 174.51 crore.
Effective tax rate was 25.14% compared to 20.64%.
Minority
interest decreased 4.27% to Rs 4.26 crore. Net profit attributable to owners of
the company decreased 1.61% to Rs 655.76 crore.
Promoters’
stake was 44.93% as of 31 March 2021 compared to 44.80% as of 31 March 2020. Promoters pledged stake was 1.50% as of 31
March 2021 compared to 3.76% as of 31 March 2020.
Cash
flow from operating activities decreased to Rs 717.95 crore for year ended
March 2021 from Rs 881.38 crore for year ended March 2020. Cash flow used in acquiring fixed assets
during the year ended March 2021 stood at Rs 322.54 crore, compared to Rs
373.99 crore during the year ended March 2020.
The
scrip is currently trading at Rs 9254
Atul : Consolidated Results
|
Particulars
|
2106 (03)
|
2006 (03)
|
Var.(%)
|
2103 (12)
|
2003 (12)
|
Var.(%)
|
Net
Sales
|
1,080.20
|
660.56
|
64
|
3,731.47
|
4,093.06
|
-9
|
OPM
(%)
|
21.9
|
24.0
|
|
24.58
|
22.0
|
|
OP
|
236.11
|
158.66
|
49
|
917.12
|
902.01
|
2
|
Other
Inc.
|
29.62
|
40.64
|
-27
|
102.98
|
78.04
|
32
|
PBIDT
|
265.73
|
199.3
|
33
|
1,020.10
|
980.05
|
4
|
Interest
|
2.06
|
2.67
|
-23
|
9.35
|
9.4
|
-1
|
PBDT
|
263.67
|
196.63
|
34
|
1,010.75
|
970.65
|
4
|
Depreciation
|
43.26
|
33.12
|
31
|
136.32
|
130.21
|
5
|
PBT
|
220.41
|
163.51
|
35
|
874.43
|
840.44
|
4
|
Share
of Profit/(Loss) from Associates
|
1.94
|
0.28
|
593
|
7.25
|
4.98
|
46
|
PBT
before EO
|
222.35
|
163.79
|
36
|
881.68
|
845.42
|
4
|
EO
Income
|
0
|
0
|
-
|
0
|
0
|
-
|
PBT
after EO
|
222.35
|
163.79
|
36
|
881.68
|
845.42
|
4
|
Taxation
|
57.2
|
45.85
|
25
|
221.66
|
174.51
|
27
|
PAT
|
165.15
|
117.94
|
40
|
660.02
|
670.91
|
-2
|
Minority
Interest (MI)
|
-0.79
|
0.16
|
LP
|
4.26
|
4.45
|
-4
|
Net
profit
|
165.94
|
117.78
|
41
|
655.76
|
666.46
|
-2
|
EPS
(Rs)*
|
#
|
#
|
|
221.6
|
225.3
|
|
Notes
|
*
EPS is on current equity of Rs 29.59 crore, Face value of Rs 10, Excluding
extraordinary items.
|
#
EPS is not annualised
|
bps
: Basis points
|
EO
: Extraordinary items
|
Figures
in Rs crore
|
Source:
Capitaline Corporate Database
|
Atul : Consolidated Segment Results
|
|
% of (Total)
|
2106 (03)
|
2006 (03)
|
Var.(%)
|
% of (Total)
|
2103 (12)
|
2003 (12)
|
Var.(%)
|
Sales
|
Life
Science Chemicals
|
31
|
352.49
|
270.86
|
30
|
31
|
1,216.37
|
1,251.95
|
-3
|
Performance
& Other Chemicals
|
67
|
753.51
|
420.49
|
79
|
67
|
2,621.88
|
2,984.50
|
-12
|
Others
|
1
|
14.7
|
8.71
|
69
|
1
|
48.48
|
36.83
|
32
|
Total
Reported Sales
|
100
|
1,120.70
|
700.06
|
60
|
100
|
3,886.73
|
4,273.28
|
-9
|
Less:
Inter segment revenues
|
|
40.5
|
39.5
|
3
|
|
155.26
|
180.22
|
-14
|
Net
Sales
|
|
1,080.20
|
660.56
|
64
|
|
3,731.47
|
4,093.06
|
-9
|
PBIT
|
Life
Science Chemicals
|
24
|
49.29
|
51.04
|
-3
|
27
|
219.57
|
223.16
|
-2
|
Performance
& Other Chemicals
|
75
|
156.33
|
85.55
|
83
|
72
|
594.16
|
603.97
|
-2
|
Others
|
2
|
3.52
|
-0.52
|
LP
|
1
|
11.3
|
11.13
|
2
|
Total
PBIT
|
100
|
209.14
|
136.07
|
54
|
100
|
825.03
|
838.26
|
-2
|
Less
: Interest
|
|
2.06
|
2.67
|
-23
|
|
9.35
|
9.4
|
-1
|
Add:
Other un-allcoable
|
|
15.27
|
30.39
|
-50
|
|
66
|
16.56
|
299
|
PBT
|
|
222.35
|
163.79
|
36
|
|
881.68
|
845.42
|
4
|
|
|
Previous News |
Atul
(
Results
-
Analysis
26-Apr-22
22:52
)
|
|
Atul standalone net profit declines 40.45% in the March 2023 quarter
(
Results
-
Announcements
28-Apr-23
15:41
)
|
|
Atul consolidated net profit declines 32.38% in the December 2022 quarter
(
Results
-
Announcements
20-Jan-23
15:35
)
|
|
Atul to hold board meeting
(
Corporate News
-
04-Nov-23
10:37
)
|
|
Board of Atul recommends Final Dividend
(
Corporate News
-
29-Apr-23
09:35
)
|
|
Atul to table results
(
Corporate News
-
30-Sep-22
12:48
)
|
|
Atul receives credit ratings for proposed CP issue of Rs 300 cr
(
Corporate News
-
26-Nov-21
13:19
)
|
|
Atul appoints director
(
Corporate News
-
26-Apr-22
16:18
)
|
|
Board of Atul recommends Final Dividend
(
Corporate News
-
26-Apr-22
16:11
)
|
|
Atul to discuss results
(
Corporate News
-
31-Mar-22
09:44
)
|
|
Atul consolidated net profit declines 22.16% in the March 2022 quarter
(
Results
-
Announcements
26-Apr-22
15:33
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|